Professor Sang-Hyun Kim
Boramae Hospital, Seoul (Korea (Republic of))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/880x255/9cd18bf278/acvc-acronym-text-rgb.png)
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Professor Kim's research focuses on the management of dyslipidemia and other risk factors to prevent cardiovascular disease.
He is especially interested in evaluation of traditional and new risk factors and their attributable risks in Asian people. He participated in the process of Asian treatment guideline with the emphasis on treatment gap and patient compliance for the dyslipidemia management.
New clinical outcomes of Fimasartan
Event: ESC Congress 2022
Topic: Hypertension
Session type: Satellite Symposium
ESC 365 is supported by
